BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

Back to rankings

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

Upgrade to unlock
New
Increased
Maintained
Reduced
Closed

more call options, than puts

Call options by funds: $ | Put options by funds: $
Holders
616
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
8
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
$48M
Puts
$8.03M
Net Calls
Net Calls Change

Top Buyers

1
+$150M
2
+$107M
3
+$91.4M
4
Viking Global Investors
Viking Global Investors
Connecticut
+$78.3M
5
ACM
Abrams Capital Management
Massachusetts
+$69.8M

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
76
$2.16M
77
$2.15M
78
$2.11M
79
$2.04M
80
$1.97M
81
$1.96M
82
$1.94M
83
$1.92M
84
$1.89M
85
$1.87M
86
$1.84M
87
$1.77M
88
$1.74M
89
$1.7M
90
$1.66M
91
$1.66M
92
$1.65M
93
$1.58M
94
$1.58M
95
$1.56M
96
$1.55M
97
$1.53M
98
$1.5M
99
$1.5M
100
$1.5M
2 3
4
5 6